Credit Suisse Ag Aspira Women'S Health Inc. Transaction History

Credit Suisse Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.4 - $1.09 $15,570 - $42,428	-38,925 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.88 - $1.81 $1,812 - $3,728	2,060 Added 5.59%	38,925 $40,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $1,046 - $2,202	642 Added 1.77%	36,865 $64,000
Q3 2021 Nov 12, 2021	SELL	$3.19 - $5.48 $159 - $274	-50 Reduced 0.14%	36,223 $117,000
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $173,384 - $248,107	36,273 New	36,273 $204,000

Q1 2021 May 14, 2021	SELL	$5.9 - $9.13 $129,923 - $201,051	-22,021 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.0 - $6.71 $66,063 - $147,760	22,021 New	22,021 $148,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $185M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.